A Composite Model for the Transport of Hydrophilic and Lipophilic Compounds Across the Skin: Steady-State Behavior

    September 2018 in “ Journal of pharmaceutical sciences
    Gerald B. Kasting, Matthew A. Miller, Terri D. LaCount, Joanna Jaworska
    TLDR The model better predicts how water-loving and fat-loving substances move through the skin by including tiny pores and hair follicle paths.
    The study developed a composite model for the transport of hydrophilic and lipophilic compounds across the skin, focusing on steady-state behavior. It incorporated two main pathways: aqueous shunts in hair follicles and transcellular transport through lipid bilayer defects. The model effectively explained steady-state permeabilities, desorption rates, and partition coefficients for both polar and lipophilic solutes using in vitro data from excised human skin. It aimed to predict skin transport for a wide range of solutes, providing valuable insights for dermal risk assessments and product development. The model's predictions were consistent with experimental data, highlighting the importance of the follicular pathway in transdermal drug delivery.
    Discuss this study in the Community →

    Research cited in this study

    5 / 5 results

    Related Community Posts Join

    6 / 1000+ results
      FCE 28260: A Forgotten 5α-Reductase Inhibitor

      community FCE 28260: A Forgotten 5α-Reductase Inhibitor

      in Research  330 upvotes 3 months ago
      FCE 28260 (PNU 156765), an under-explored 5α-reductase inhibitor, showcases promising results in research by Giudici et al., outperforming well-known treatments like Finasteride in reducing the conversion of testosterone to DHT. Its superior efficacy, demonstrated through lower IC50 values in both natural and human recombinant enzyme studies, suggests it could offer more effective management of DHT-related conditions. Additionally, its lower molecular weight hints at better potential for topical application, potentially offering advantages in treating conditions such as androgenic alopecia. Despite its potential, it has not advanced in development, possibly due to financial limitations, leaving its therapeutic prospects and side effect profile largely unexplored.

      community He used Dutasteride for 20 years. Interview

      in Treatment  109 upvotes 1 month ago
      Dutasteride has been used for 20 years with some hair thickness improvement but no dramatic regrowth. The user also experimented with minoxidil, tretinoin, and peptides like BPC 157 for potential benefits in hair density and quality.

      community Why nobody uses 0.25% (2.5mg/ml)?

      in Treatment  66 upvotes 11 months ago
      The conversation is about the effectiveness of 0.25% topical finasteride compared to other concentrations and forms. Users discuss its potential for better scalp DHT reduction and fewer side effects, with some preferring topical over oral treatments.

    Similar Research

    5 / 1000+ results